"As you were not around at the time, let me help you understand that CEPH (Dec 2010) was a $3.5bn mkt cap company with a $2.5bn turnover at the time. History will tell you CEPH paid $350M to Mesoblast in partnering Revacsor + cord blood ( plus $1.7bn on agreed milest0nes)."
@4Seasons,
Tell me: did Cephalon at the time carry a quantum of Net Debt equal to 125% of its Market Value?
(A little bit of knowledge can sometimes be a dangerous thing, I have found)
".....are we about to experience Dec 2010 all over again ?"
Possibly. Who really knows?
But hope so, for the sake of long-term MSB shareholders (although I can't help but recalling that that sort of hopeful sentiment about partnership funding being imminent has been a feature of MSB threads on HotCopper for many years. But, as I say, this time might be the one...)
My thoughts on what matters to MNK, page-15
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.000(0.00%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 198 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 3627 | 1 |
View Market Depth
| Last trade - 09.37am 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable